Which fluid biomarkers can be used alongside 3R, 4R, and TDP-43 for the diagnosis and management of tauopathies?
Fluid biomarkers such as CSF and plasma p-tau isoforms, MTBR-tau243, and their correlations with tau PET imaging provide valuable, albeit imperfect, tools in the diagnosis and management of tauopathies. Improved biomarker specificity and validation across tauopathy spectra remain crucial.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-10-29
- DOI
- https://doi.org/10.5281/zenodo.23766798
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00